Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGA4 | P13612 | 6/20 | 0.38 |
| ▸ | ITGB7 | P26010 | 6/20 | 0.38 |
| ▸ | BRD9 | Q9H8M2 | 3/20 | 0.38 |
| ▸ | BRD4 | O60885 | 1/20 | 0.38 |
| ▸ | BRPF1 | P55201 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | ATM | Q13315 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | GLA | P06280 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | CASP1 | P29466 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | CASP7 | P55210 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 3/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.35 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22016864 | 0.76 | ALDH1A1 (0.41) | ITGA4ITGB7BRD9BRD4ALDH1A1 | |
| SCHEMBL466352 | 0.74 | ALDH1A1 (0.55) | BRD9BRD4ALDH1A1ATMGAA | |
| SCHEMBL31735616 | 0.74 | BPTF (0.46) | BRD9BRD4BRPF1ALDH1A1GAA | |
| SCHEMBL4498149 | 0.74 | RAB9A (0.55) | ITGA4ITGB7BRD9ALDH1A1ATM | |
| SCHEMBL21737683 | 0.73 | CYP11B2 (0.40) | ITGA4ITGB7BRD9ALDH1A1ATM | |
| SCHEMBL466422 | 0.72 | ITGA4 (0.42) | ITGA4ITGB7BRD9BRD4ALDH1A1 | |
| SCHEMBL22031949 | 0.71 | KAT2B (0.39) | ITGA4ITGB7BRD9BRPF1ALDH1A1 | |
| SCHEMBL3055509 | 0.71 | ALDH1A1 (0.36) | ITGA4ITGB7BRD9ALDH1A1ATM | |
| SCHEMBL20956636 | 0.70 | CA12 (0.43) | ITGA4ITGB7ALDH1A1KDM4EHTT | |
| SCHEMBL24312389 | 0.69 | LMNA (0.53) | BRD9BRD4BRPF1KDM4ERAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11224600-B2 | Compounds for inhibition of alpha 4 beta 7 integrin | GILEAD SCIENCES, INC. (US) | 2022-01-18 | — | — | US | disclosed |
| US-20200155563-A1 | COMPOUNDS FOR INHIBITION OF ALPHA 4 BETA 7 INTEGRIN | GILEAD SCIENCES, INC. | 2020-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200155563-A1 | COMPOUNDS FOR INHIBITION OF ALPHA 4 BETA 7 INTEGRIN | ITGB7, ITGB4, ITGA4 | ITGA4 3/4885ITGB7 1/4885BRD9 1617/4885 |
| US-11224600-B2 | Compounds for inhibition of alpha 4 beta 7 integrin | ITGB7, ITGB4, ITGA4 | ITGA4 3/4885ITGB7 1/4885BRD9 1617/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.